Home›Antineoplastic and Immunomodulating Agents›Approval Status›ApprovedBrowse ByApprovedThis dimension marks a drug's current approval status, approved, withdrawn or investigational. Wikipedia notes that "governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing," regulation that always includes a formal approval decision. Browsing by approval status separates drugs currently approved from those that are not.FactsApprovedSourcesComments (0)Reader Challenges (0)FactsComparisonATC Level 1 CodeWell-attestedSourced to the subject's own accountL - Antineoplastic and immunomodulating agents 1ApprovedFilter Results52 entriesTreats (Condition)AllBreast Cancer (1)Cancer (2)Rheumatoid Arthritis (1)Era (First Approved)All1947 (1)1949 (1)1959 (1)1963 (1)1969 (2)1973 (2)1974 (1)1975 (1)1976 (1)1977 (1)1978 (1)1983 (2)1992 (1)1994 (1)1999 (1)2001 (1)2005 (1)2010 (1)2013 (1)2015 (2)2017 (1)2018 (3)2019 (1)2020 (5)2021 (6)2022 (2)2023 (4)2024 (3)2025 (1)2026 (1)ATC ClassAllL: Antineoplastic and Immunomodulating Agents (52)Route of AdministrationAllIntravenous (26)Ophthalmic (1)Oral (18)Subcutaneous (3)Topical (2)WHO Essential MedicineAllComplementary List (12)BrowseCompareSelect all 52AbraxaneApprovedActemraApprovedAllogeneic processed thymus tissueApprovedAmivantamab/hyaluronidaseApprovedAxicabtagene ciloleucelApprovedBinimetinibApprovedBleomycinApprovedBrexucabtagene autoleucelApprovedCarmustineApprovedCiclosporinApprovedCisplatinApprovedCobimetinibApprovedCytarabineApprovedDacarbazineApprovedDecitabine/cedazuridineApprovedEncorafenibApprovedEtoposideApprovedFedratinibApprovedFruquintinibApprovedIdecabtagene vicleucelApprovedImatinibApprovedInterleukin 2ApprovedLifileucelApprovedLisocabtagene maraleucelApprovedLomustineApprovedMelphalan flufenamideApprovedMethotrexateApprovedMitomycin CApprovedMotixafortideApprovedNadofaragene firadenovecApprovedNiraparib/abiraterone acetateApprovedNitrogen mustardApprovedOmidubicelApprovedPanobinostatApprovedProcarbazineApprovedRipretinibApprovedSacituzumab govitecanApprovedSepsivacApprovedTabelecleucelApprovedTagraxofuspApprovedTamoxifenApprovedTemozolomideApprovedTeserpaturevApprovedThiotepaApprovedTislelizumabApprovedTivozanibApprovedTrametinibApprovedTucatinibApprovedVincristineApprovedVinorelbineApprovedVorasidenibApprovedVusolimogene oderparepvecApprovedSources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3WikipediaATC Level 1 codes table, group LQuote, ATC Level 1 codes table, group LL - "Antineoplastic and immunomodulating agents"View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.